COLLECTIONS
WORKFLOWS
Harbour BioMed (HBM Holdings; HKEX: 02142) is a global, clinical-stage biopharmaceutical company focused on the discovery and development of novel/differentiated antibody therapeutics, including in areas such as oncology/immuno-oncology and immunology.
Focus Areas
Notable Investments
